17 reports

UC IS KNOWN TO BE ASSOCIATED WITH AUTOIMMUNE DISEASES, INCLUDING AUTOIMMUNE HEPATITIS AND AUTOIMMUNE PANCREATITIS.

  • Autoimmune Disease
  • Japan
  • Spain
  • Pfizer Inc.
  • Remicade group

GLOBAL EPIDEMIOLOGY OF PSORIASIS PSORIASIS IS ONE OF THE MOST PREVALENT AUTOIMMUNE DISEASE IN THE ACROSS THE GLOBE.

  • Autoimmune Disease
  • Japan
  • World
  • Amgen Inc.
  • Sandoz Inc.
  • 7.2 INCREASED AWARENESS AMONG DERMATOLOGISTS AND PRIMARY CARE
  • ELI LILLY'S PSA PORTFOLIO ASSESSMENT, 2015

Janus kinase inhibitors in autoimmune diseases.

  • Autoimmune Disease
  • Japan
  • Amgen Inc.
  • Pfizer Inc.
  • Remicade group
  • 4.5.3 Sex-Specific Diagnosed Prevalent Cases of Primary SS

Opportunity Analyzer: Sjögren’s Syndrome - Opportunity Analysis and Forecast to 2024 Summary Sjögren’s syndrome (SS) is a slow progressing chronic autoimmune disease, which predominantly affects middle-aged women, and is characterized by lymphocytic infiltration of the exocrine glands, mainly the lacrimal and salivary...

  • Autoimmune Disease
  • Japan
  • Allergan plc
  • GlobalData's company
  • Novartis AG

Musculoskeletal Disease; ##(##): ##-##.

  • Autoimmune Disease
  • Pathology
  • Japan
  • Forecast
  • GlobalData's company
  • PRODUCT PROFILE - MYCOPHENOLATE MOFETIL
  • GC SWOT ANALYSIS, 2015

Opportunity Analyzer: Vasculitis - Opportunity Analysis and Forecast to 2024 Summary Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, arteries, veins or capillaries. The different forms of vasculitis are classified by the size and location of the affected blood vessels...

  • Autoimmune Disease
  • Japan
  • GlobalData's company
  • Remicade group
  • Roche Group
  • APR 25, 2017: AUTOIMMUNE DISEASE USE PATENT FOR EP4 ANTAGONIST APPROVED IN JAPAN

Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Pipeline Review, H2 2018 Summary Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) - Prostaglandin E2 receptor 4 (EP4) is a prostaglandin receptor encoded by the PTGER4 gene. The activity of the receptor...

  • Autoimmune Disease
  • Pharmaceutical
  • Japan
  • Product Initiative
  • Eisai Co., Ltd.

Psoriatic arthritis

4546 5000 3864
  • PRODUCT PROFILE

Psoriatic arthritis Disease Coverage | Forecast: Psoriatic Arthritis DMKC## US ## ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## ## ## Spain ## ##

  • Autoimmune Disease
  • Japan
  • Amgen Inc.
  • Celgene Corporation
  • Johnson & Johnson

According to the National Psoriasis Foundation (NPF), psoriasis is the most prevalent autoimmune disease in the US, affecting approximately ##. ##% of the population (NPF, 2015).

  • Autoimmune Disease
  • Pathology
  • Japan
  • United States
  • Forecast

THERAPEUTIC POTENTIAL OF INTERLEUKIN-## IN INFLAMMATION AND AUTOIMMUNE DISEASES.

  • Autoimmune Disease
  • Japan
  • Amgen Inc.
  • GlobalData's company
  • Remicade group

Enbrel binds specifically to circulating TNF and blocks its interaction with cell surface TNF receptors, thereby retarding inflammation in autoimmune diseases.

  • Autoimmune Disease
  • Japan
  • Celgene Corporation
  • Johnson & Johnson
  • Novartis AG

The company develops drugs for various therapeutic diseases such as cancer, autoimmune, osteoporosis, infectious, and central nervous system diseases, pathological blood clots, rejection reaction in organ transplantation and other severe clinical conditions.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Japan
  • Product Initiative
  • Takeda Pharmaceutical Company Limited

About focuSSced Genentech continues to explore treatments for autoimmune diseases with significant unmet needs.

  • Autoimmune Disease
  • Pharmaceutical
  • Therapy
  • Japan
  • Chugai Pharmaceutical Co., Ltd.

RhuDex is a modifying agent for the oral treatment of autoimmune diseases.

  • Autoimmune Disease
  • Japan
  • Company
  • Deals & Alliance
  • Dr. Falk Pharma GmbH

C##AR IS A COMPONENT OF THE BODY' S COMPLEMENT SYSTEM AND A POTENT DRIVER OF THE INFLAMMATORY RESPONSE ASSOCIATED WITH AUTOIMMUNE DISEASES.

  • Autoimmune Disease
  • Hospital
  • Monoclonal Antibody
  • Japan
  • Product Initiative
  • KRP-203 - Drug Profile

Kyorin grants Novartis with exclusive rights to develop and commercialize KRP-## worldwide except in Japan, Korea, China and Taiwan for use in organ transplants, autoimmune diseases, and inflammatory bowel disease.

  • Autoimmune Disease
  • Japan
  • Company Operations
  • Product Initiative
  • Kyorin Pharmaceutical Co., Ltd.

Psoriasis

4546 5000 3864
  • PRODUCT PROFILE

BIBLIOGRAPHY Psoriasis Disease Coverage | Forecast: Psoriasis DMKC## US ## ## ## ## ## ## ## ## ## ## Japan ## ## ## ## ## ## ## ## ## ## France ## ## ## ## ## ## ## ## ## ## Germany ## ## ## ## ## ## ## ## ## ## Italy ## ## ## ## ## ## ## ## ## ## Spain ## ## ## ## ## ## ## ## ## ## UK ##

  • Autoimmune Disease
  • Therapy
  • Japan
  • North America
  • Amgen Inc.